… of bacterial isolates, β-lactam-β lactamase inhibitors should be used with caution when
treating serious infection caused by ESBL-producing K. pneumoniae as in vitro susceptibility may …

… of extended spectrum β-lactamase (ESBL) in multi drug resistant (MDR) strains of Klebsiella
pneumoniae isolated from different clinical samples… Methods: A total of 120 MDR strain of K. …

… Because of recurrent colonization by Klebsiella pneumoniae strains producing type SHV-4
extended-spectrum b-lactamases (ESBLs), a case-control study was conducted in an …

… Klebsiella pneumoniae to carbapenems is mainly associated with acquired carbapenem-hydrolyzing
β-lactamases … clinical Klebsiella pneumoniae isolates that produce β-lactamase bla …

… The emergence of extended-spectrum β-lactamase (ESBL)-producing bacteria, particularly
Escherichia coli and Klebsiella pneumoniae, is now a critical concern for the development of …

… The worldwide spread of extended-spectrum β-lactamase (ESBL)-producing bacteria,
particularly Escherichia coli and Klebsiella pneumoniae, is a critical concern for the development …

… Increasing prevalence of KPC-2–producing K. pneumoniae coincided with decreasing
prevalence of metallo-β lactamase–producing isolates in our ICU. Multidrug resistance …

… For the reasons given below, the AmpC β-lactamases detected in K. pneumoniae
isolates in this study are referred to as imported AmpC β-lactamases. …

… We investigated the diversity of the chromosomal class A beta-lactamase gene in Klebsiella
pneumoniae in order to study the evolution of the gene. A 789-bp portion was sequenced in …

Four isolates of Klebsiella pneumoniae obtained from patients at a Maryland medical centre
exhibited reduced susceptibility to carbapenems and were found to produce the novel, class …